承诺,投资和交付:通过在中国发现活跃病例和进行预防治疗,实现终结结核病战略目标
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
China CDC weekly
|April 14, 2025
概括
中国可以通过将活跃病例发现和结核病预防治疗 (TPT) 整合到零结核病社区,结束结核病 (TB). 该战略与减少结核病发病率和传播的国家计划保持一致,旨在消除流行病.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 传染病控制和控制传染病
背景情况:
- 2025年世界结核病日的主题强调了结束结核病的目标.
- 中国在结核病流行方面面临重大挑战.
- "国家结核病预防和控制计划 (2024-2030) "为行动提供了一个框架.
研究的目的:
- 分析中国的结核病流行和挑战.
- 评估结核病发现和结核病预防治疗 (TPT) 的整合,以结束结核病.
- 与建立零结核病社区的国家战略保持一致.
主要方法:
- 对中国结核病流行病数据的全面分析.
- 审查国家结核病预防和控制计划.
- 评估活跃病例发现和TPT的作用.
主要成果:
- 发现活跃病例对于早期检测和减少结核病传播至关重要.
- 结核病预防治疗 (TPT) 对于降低潜伏结核病感染至关重要.
- 整合这些战略支持零结核病社区的发展.
结论:
- 通过积极寻找病例和TPT建立零结核病社区是中国的一个可行的战略.
- 政府的承诺,资源分配和协调实施是关键.
- 预计这种方法将导致结核病流行病的消除.
相关概念视频
Pulmonary Tuberculosis V
157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
Pulmonary Tuberculosis II
201
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
201
Pulmonary Tuberculosis I
208
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
208
Pulmonary Tuberculosis III
267
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
267
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


